US pharma giant Merck & Co (NYSE: MRK) has announced financial results for the fourth quarter and full year of 2025. Merck’s ...
Cambridge, USA-based precision medicines specialist Relay Therapeutics today announced that the US Food and Drug ...
The UK and Japan have announced a major package of science and technology collaborations, it has been announced.
The Coalition for Epidemic Preparedness Innovations (CEPI) and South Korea’s Samsung Biologics, a contract development and manufacturing organization (CDMO), today announced a partnership to ...
Pfizer (NYSE: PFE) posted fourth-quarter 2025 revenue of about $18 billion, down 1% from the year-ago quarter, and adjusted ...
US pharma giant Pfizer today announced positive top-line results from the Phase IIb VESPER-3 study investigating monthly ...
Privately-held RNAi therapeutics specialist SanegeneBio has announced a global licensing agreement with the Roche subsidiary Genentech.
A Paris-based biotech/deeptech company developing rapid microbiology testing for industrial quality control. Its deployment ...
A privately held ophthalmic company headquartered in Southern California (Aliso Viejo). The company’s development work is ...
Cambridge, UK-based biotech Bicycle Therapeutics, which is pioneering a new and differentiated class of therapeutics based on ...
Danish drugmaker Novo Nordisk has announced headline results from REIMAGINE 2, a Phase III study from the global REIMAGINE clinical trial program.
China-based biologics CDMO WuXi Biologics (HKEX: 2269) has signed a license and research services agreement with US biotech Vertex Pharmaceuticals (Nasdaq: VRTX) covering a preclinical trispecific ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results